Holt D - Search Results

1

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model.

Ma X, Norsworthy K, Kundu N, Rodgers WH, Gimotty PA, Goloubeva O, Lipsky M, Li Y, Holt D, Fulton A. Ma X, et al. Among authors: holt d. Mol Cancer Ther. 2009 Mar;8(3):490-8. doi: 10.1158/1535-7163.MCT-08-0485. Epub 2009 Mar 10. Mol Cancer Ther. 2009. PMID: 19276169

2

Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4.

Holt DM, Ma X, Kundu N, Collin PD, Fulton AM. Holt DM, et al. J Immunother. 2012 Feb-Mar;35(2):179-88. doi: 10.1097/CJI.0b013e318247a5e9. J Immunother. 2012. PMID: 22306906 Free PMC article.

3

Antagonism of the prostaglandin E receptor EP4 inhibits metastasis and enhances NK function.

Kundu N, Ma X, Holt D, Goloubeva O, Ostrand-Rosenberg S, Fulton AM. Kundu N, et al. Among authors: holt d. Breast Cancer Res Treat. 2009 Sep;117(2):235-42. doi: 10.1007/s10549-008-0180-5. Epub 2008 Sep 16. Breast Cancer Res Treat. 2009. PMID: 18792778 Free PMC article.

4

Prostaglandin E(2) (PGE (2)) suppresses natural killer cell function primarily through the PGE(2) receptor EP4.

Holt D, Ma X, Kundu N, Fulton A. Holt D, et al. Cancer Immunol Immunother. 2011 Nov;60(11):1577-86. doi: 10.1007/s00262-011-1064-9. Epub 2011 Jun 17. Cancer Immunol Immunother. 2011. PMID: 21681369 Free PMC article.

5

Antimetastatic activity isolated from Colocasia esculenta (taro).

Kundu N, Campbell P, Hampton B, Lin CY, Ma X, Ambulos N, Zhao XF, Goloubeva O, Holt D, Fulton AM. Kundu N, et al. Among authors: holt d. Anticancer Drugs. 2012 Feb;23(2):200-11. doi: 10.1097/CAD.0b013e32834b85e8. Anticancer Drugs. 2012. PMID: 21934603 Free PMC article.

6

Prostaglandin E2 EP receptors as therapeutic targets in breast cancer.

Reader J, Holt D, Fulton A. Reader J, et al. Among authors: holt d. Cancer Metastasis Rev. 2011 Dec;30(3-4):449-63. doi: 10.1007/s10555-011-9303-2. Cancer Metastasis Rev. 2011. PMID: 22002714 Free PMC article. Review.

7

A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE₂-mediated immunosuppression and inhibits breast cancer metastasis.

Ma X, Holt D, Kundu N, Reader J, Goloubeva O, Take Y, Fulton AM. Ma X, et al. Among authors: holt d. Oncoimmunology. 2013 Jan 1;2(1):e22647. doi: 10.4161/onci.22647. Oncoimmunology. 2013. PMID: 23482441 Free PMC article.

8

Enhancing social functioning using multi-user, immersive virtual reality.

Holt DJ, DeTore NR, Aideyan B, Utter L, Vinke L, Johnson DS, Zimmerman J, Dokholyan KN, Burke A. Holt DJ, et al. Sci Rep. 2025 Jan 22;15(1):2790. doi: 10.1038/s41598-024-84954-4. Sci Rep. 2025. PMID: 39843493 Free PMC article.

9

The role of GLP-1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system.

Kanellis C, Williams K, Holt DQ, Wong J, David R, Carothers R, Le S. Kanellis C, et al. Among authors: holt dq. Med J Aust. 2025 Jan 9. doi: 10.5694/mja2.52582. Online ahead of print. Med J Aust. 2025. PMID: 39789665 No abstract available.

10

Policy brief: Improving national vaccination decision-making through data.

Evans S, Schmitt J, Kalra D, Sokol T, Holt D. Evans S, et al. Among authors: holt d. Front Public Health. 2024 Dec 17;12:1407841. doi: 10.3389/fpubh.2024.1407841. eCollection 2024. Front Public Health. 2024. PMID: 39741942 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,192 results

Search Page

Filters